Business
Press Release Nov 23 2021
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 23, 2021, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 150 mg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 23, 2021, titled \"Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 150 mg\". View Attachment","length":420,"tagName":"div"}]